TrialAnnals of surgical oncology2023
The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study.
Jia-Ying Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it